Michelle Burris
Keine laufenden Positionen mehr
Vermögen: 135 603 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Michelle Burris
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT.
34
| Subsidiary | Biotechnology | 34 |
OncoGenex Pharmaceuticals, Inc.
 OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA.
18
| Extinct | Pharmaceuticals: Major | 18 |
Sonus Pharmaceuticals, Inc.
 Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA.
12
| Extinct | Pharmaceuticals: Major | 12 |
Emergent Product Development Seattle
 Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
| Extinct | Medical Specialties | 6 | |
Polynoma LLC
 Polynoma LLC BiotechnologyHealth Technology Part of CK Life Sciences International (Holdings), Inc., Polynoma LLC is an immuno-oncology focused biopharmaceutical company headquartered in San Diego, CA. Polynoma's lead asset is a novel polyvalent antigen vaccine, Seviprotimut-L, for the prevention of recurrence of melanoma. The vaccine has been safely administered in more than 1,000 patients. Polynoma is an immuno-oncology company developing a novel polyvalent antigen therapy for the treatment of melanoma. The company was founded by Paul A. Hopper.
3
| Subsidiary | Biotechnology | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Michelle Burris
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Graduate Degree Masters Business Admin Masters Business Admin Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Corporate Officer/Principal Undergraduate Degree | |
| ACHIEVE LIFE SCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member President Chief Executive Officer Comptroller/Controller/Auditor | |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Biotechnology | Director of Finance/CFO Chief Executive Officer Chief Executive Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO General Counsel Chief Tech/Sci/R&D Officer | |
| Montana State University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| PDL BIOPHARMA, INC. | Biotechnology | Director/Board Member Chief Executive Officer General Counsel | |
| ALZA CORPORATION | Pharmaceuticals: Major | Chairman Corporate Officer/Principal Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Washington Biotechnology & Biomedical Association | Director/Board Member Chairman Director/Board Member | ||
Theraclone Sciences, Inc.
 Theraclone Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Theraclone Sciences, Inc. develops novel therapeutic antibodies for the treatment of cancer and infectious diseases. The firm leverages its proprietary antibody discovery technology, I-STARTM to identify rare fully human antibodies from immunologically relevant human subjects. The firm’s primary research focus is to discover novel targets and antibodies, and develop therapeutic monoclonal antibodies, by using its proprietary B-cell technology platform to mine the immune system of cancer patients. The company was founded by Johnny T. Stine in November 2004 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Chairman President Director of Finance/CFO | |
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing General Counsel Sales & Marketing | |
| AMGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| OMEROS CORPORATION | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| CODEXIS, INC. | Chemicals: Specialty | Director/Board Member Director/Board Member | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| ICOSAVAX, INC. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
| VBI VACCINES INC. | Biotechnology | Director/Board Member Chairman | |
| University of California, Berkeley | College/University | Graduate Degree Graduate Degree | |
| SEAGEN INC. | Pharmaceuticals: Major | Chief Operating Officer General Counsel | |
| The Johns Hopkins University | College/University | Doctorate Degree Undergraduate Degree | |
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Director/Board Member | |
| IMMUNE DESIGN CORP | Pharmaceuticals: Major | Founder Corporate Officer/Principal | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Corporate Officer/Principal Undergraduate Degree | |
| Seattle University | College/University | Masters Business Admin Masters Business Admin | |
| AMBIT BIOSCIENCES CORP | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| Western Washington University | College/University | Undergraduate Degree Undergraduate Degree | |
| PHASERX, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Dartmouth College | College/University | Doctorate Degree Undergraduate Degree | |
| Thomas Jefferson University | College/University | Graduate Degree Doctorate Degree | |
OncoResponse, Inc.
 OncoResponse, Inc. BiotechnologyHealth Technology OncoResponse, Inc. discovers cancer immunotherapies by interrogating the human immune system. The firm identifies elite responders to immunotherapy and screens the adaptive immune system to discover antibodies with reactivity. The company was founded by Clifford J. Stocks, Kristine Swiderek and Steven H. Gillis in 2015 and is headquartered in Seattle, WA. | Biotechnology | Director/Board Member Director of Finance/CFO | |
Hibercell, Inc.
 Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Hibercell, Inc. specializes on tumor dormancy detection and therapeutics. It provides treatment for primary tumors, metastatic cancer. The company was founded by Alan Rigby, Julio Aguirre-Ghiso, and Ari Nowacek and is headquartered in New York, NY. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| University of British Columbia | College/University | Corporate Officer/Principal Undergraduate Degree | |
Infectious Disease Research Institute
 Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Infectious Disease Research Institute operates as a innovative science to research and development company. It offers pipeline, adjuvants, vaccines, diagnostics and drugs products. The firm also provides manufacturing, analytical methods, stability studies, process and contact services. The company was founded by Steven G. Reed in 1993 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Chief Executive Officer Founder | |
| University of Illinois | College/University | Doctorate Degree Undergraduate Degree | |
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO |
Statistik
International
| Vereinigte Staaten | 46 |
| Kanada | 4 |
| Vereinigtes Königreich | 2 |
| Schweden | 2 |
Sektoral
| Health Technology | 33 |
| Consumer Services | 12 |
| Commercial Services | 5 |
| Process Industries | 2 |
| Finance | 2 |
Operativ
| Director/Board Member | 303 |
| Corporate Officer/Principal | 162 |
| Independent Dir/Board Member | 82 |
| Chief Tech/Sci/R&D Officer | 66 |
| Undergraduate Degree | 61 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Steven Gillis | 58 |
| Peter Thompson | 39 |
| Mark McDade | 35 |
| George Dunbar | 31 |
| Ron Hunt | 29 |
| Samuel Saks | 28 |
| Michael Bigham | 27 |
| Kenneth Bailey | 23 |
| H. Parker | 22 |
| Michelle Griffin | 18 |
| David Smith | 17 |
| Alan Fuhrman | 17 |
| Julia Eastland | 16 |
| Robert Hershberg | 16 |
| Dwight Winstead | 15 |
- Börse
- Insiders
- Michelle Burris
- Unternehmensverbindungen
